Multiple Drug Resistance Parameter Expression in Ovarian Cancer

Author： Joncourt F.   Buser K.   Altermatt H.   Bacchi M.   Oberli A.   Cerny T.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.70, Iss.2, 1998-08, pp. : 176-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Co-expression of CD147/EMMPRIN with monocarboxylate transporters and multiple drug resistance proteins is associated with epithelial ovarian cancer progression

By Chen Hongmin   Wang Li   Beretov Julia   Hao Jingli   Xiao Weiwei   Li Yong  

Clinical and Experimental Metastasis, Vol. 27, Iss. 8, 2010-12 ,pp. : 557-569

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Lewis Y antigen on the gene expression of multiple drug resistance-associated proteins in human ovarian cancer RMG-I-H cells

By Gao Song   Liu Qing   Wang Xinyan   Lin Bei   Zhang Shulan  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 960-967

Humana Press, Inc

Access to resources Recommend Favorite

Downregulation of NEK11 is associated with drug resistance in ovarian cancer

By            

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 1266-1274

Spandidos Publications

Access to resources Recommend Favorite

Upregulation of NEK2 is associated with drug resistance in ovarian cancer

By            

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 745-754

Spandidos Publications

Access to resources Recommend Favorite

Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

By Yang Lingyun   Li Ningwei   Wang Hongjing   Jia Xibiao   Wang Xue   Luo Juan  

Oncology Reports, Vol. 28, Iss. 2, 2012-08 ,pp. : 592-600

Spandidos Publications

Access to resources Recommend Favorite